EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Given Consensus Recommendation of “Buy” by Brokerages

Posted by Dante Gardener on Jan 30th, 2026

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and two have assigned a strong buy recommendation to the company.

ESLOY has been the topic of a number of research analyst reports. The Goldman Sachs Group reissued a “buy” rating on shares of EssilorLuxottica in a report on Friday, December 5th. Kepler Capital Markets raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday, January 15th. HSBC raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. UBS Group upgraded shares of EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. Finally, Hsbc Global Res upgraded EssilorLuxottica to a “strong-buy” rating in a research report on Wednesday, January 14th.

Check Out Our Latest Analysis on EssilorLuxottica

EssilorLuxottica Price Performance

ESLOY stock opened at $153.19 on Friday. EssilorLuxottica has a fifty-two week low of $126.47 and a fifty-two week high of $186.81. The company has a quick ratio of 0.67, a current ratio of 0.97 and a debt-to-equity ratio of 0.18. The business has a fifty day moving average price of $164.30 and a 200 day moving average price of $162.62.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.